A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)
a study on Ovarian Cancer
Recurrent Platinum Resistant Ovarian Cancer Recurrent Ovarian cancer Platinum resistant ovarian cancer Ovarian cancer Ovarian carcinoma Epithelial ovarian cancer paclitaxel Ovarian Neoplasms Carcinoma, Ovarian Epithelial Albumin-Bound Paclitaxel VB-111 + Paclitaxel
Lead Scientists at UC Cancer
- Joshua Cohen (ucla)
- Krishnansu Tewari, MD (uci)
Professor, Obstetrics and Gynecology. Authored (or co-authored) 187 research publications.
- Edwin Alvarez, MD (ucsf)
Associate Professor, Ob/Gyn, Reproductive Sciences.
- Christine Holschneider, MD (ucla)
Professor of Clinical , Obstetrics and Gynecology. Authored (or co-authored) 40 research publications.